Stock Locations

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

66335-38-4Capecitabine EP Impurity A

● In Stock

Catalogue No.:	VL243001
CAS No.:	66335-38-4
Mol. Formula:	C₉H₁₂FN₃O₄
Mol. Weight:	245.21 g/mol

Request a quote

Add to RFQ list

Additional information on CAS 66335-38-4

Parent drug

Capecitabine

IUPAC Name

4-amino-1-(5-deoxy-β-D-ribofuranosyl)-5-fluoropyrimidin-2(1H)-one

Pharmacopoeial Synonyms

Capecitabine Related Compound A/5′-deoxy-5-fluorocytidine

Other Synonyms

5-Fluoro-5′-deoxycytidine

Smiles

CC2OC(n1cc(F)c(N)nc1=O)C(O)C2O

InChI

InChI=1S/C9H12FN3O4/c1-3-5(14)6(15)8(17-3)13-2-4(10)7(11)12-9(13)16/h2-3,5-6,8,14-15H,1H3,(H2,11,12,16)/t3-,5-,6-,8-/m1/s1

Shipping Condition

Ambient Temperature

Characterization Data (Included)

HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, and Structure Elucidation Report (SER).

Additional Characterization Data

QNMR, D2O Exchange, 13C NMR, 13C APT, COSY NMR, NOESY NMR, 15N NMR, HSQC NMR, HMQC NMR, and HMBC NMR. These are available upon request and may be free or subject to additional charges.

Description

Capecitabine EP Impurity A (CAS No: 66335-38-4) Or 5-Fluoro-5’-deoxycytidine,is an impurity of Capecitabine,Capecitabine delivers fluorouracil (5-FU) selectively to the tumor,Capecitabine has demonstrated activity in metastatic breast cancer, pancreatic cancer and colorectal cancer.